Immucell (ICCC) Capital Expenditures (2010 - 2026)
Immucell (ICCC) recorded Capital Expenditures of $172,306 in Q4 2025, down 12.2% from $196,216 a year earlier and down 71.0% from the prior quarter.
Powered by 
Analysis
Immucell (ICCC) Capital Expenditures (2010 - 2026) Analysis & Trends
For FY2025, Immucell reported Capital Expenditures of $1.25 million, up 168.5% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $465,725 in FY2024 (-75.4%), $1.89 million in FY2023 (-52.4%), $3.98 million in FY2022 (+52.4%) and $2.61 million in FY2021 (-35.9%).
- Quarterly Capital Expenditures has ranged from $70,356 in Q1 2024 to $1.49 million in Q4 2022 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in four of the last eight quarters, with growth averaging 106.9%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 571.8% in Q3 2025, against a decline of 94.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $593,924 (Q3 2025), $155,159 (Q2 2025) and $329,050 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Immucell | 94.09 Mn | 70.73 Mn | 2.44 Mn | 733,939.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 733,939.00 |
| Mar 31, 2026 | 177,230.00 |
| Dec 31, 2025 | 172,306.00 |
| Sep 30, 2025 | 593,924.00 |
| Jun 30, 2025 | 155,159.00 |
| Mar 31, 2025 | 329,050.00 |
| Dec 31, 2024 | 196,216.00 |
| Sep 30, 2024 | 88,412.00 |
| Jun 30, 2024 | 110,741.00 |
| Mar 31, 2024 | 70,356.00 |
| Dec 31, 2023 | -33,783.00 |
| Sep 30, 2023 | 535,642.00 |
| Jun 30, 2023 | 708,488.00 |
| Mar 31, 2023 | 682,166.00 |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 734,309.00 |
| Jun 30, 2022 | 943,290.00 |
| Mar 31, 2022 | 807,496.00 |
| Dec 31, 2021 | 704,594.00 |
| Sep 30, 2021 | 675,400.00 |
API Access
Immucell Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();